PER percheron therapeutics limited

Ann: Chief Executive Officer and Managing Director Appointment, page-35

  1. 720 Posts.
    lightbulb Created with Sketch. 210
    Cash runway in the last Quarterly 4C (9 quarters) is just cash at hand divided by that quarter’s cash outflow. The P2b trial spend hasn’t really started yet.

    When the new P2b trial was announced last September, they said they had enough cash to get to 4th quarter CY2023 (I think - please correct if in error). But that probably assumed a trial start a couple of months ago, and didn’t include the $3 mill tox study.

    3-4 qtrs of cash (max) if they start the trial soon imho. That of course ignores any cap raising/funds sourcing we are unaware of.


    Last edited by BoomCrashOffera: 08/05/23
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.9¢
Change
0.000(0.00%)
Mkt cap ! $9.786M
Open High Low Value Volume
0.9¢ 0.9¢ 0.9¢ $1.1K 126.1K

Buyers (Bids)

No. Vol. Price($)
25 6777725 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 1490666 6
View Market Depth
Last trade - 13.05pm 11/07/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.